Literature DB >> 19092396

Temporal and seasonal trends in Acanthamoeba keratitis.

Penny McAllum1, Irit Bahar, Igor Kaiserman, Sathish Srinivasan, Allan Slomovic, David Rootman.   

Abstract

PURPOSE: The purpose of this study was to assess the incidence and risk factors of Acanthamoeba keratitis (AK) over an 8-year period in a Canadian tertiary care setting.
METHODS: We retrospectively reviewed the medical records of 41 patients (42 eyes), who were diagnosed as having AK between January 1999 and December 2006 in the cornea clinic at the Toronto Western Hospital. The incidence and risk factors of AK were evaluated.
RESULTS: The number of cases per year increased from between 0 and 4 in the first 5 years to 9, 14, and 8 in the last 3 years. The annual increasing trend was statistically significant (P = 0.04). The month of onset of disease symptoms showed a trend toward onset in summer and fall and was statistically significant for the difference between January and August (P = 0.0094). The season of onset of disease symptoms showed a trend toward summer onset, and the difference between winter and summer was statistically significant (P = 0.02). 92.9% of cases occurred in contact lens wearers, particularly in soft contact lens wearers (82.1%).
CONCLUSIONS: The incidence of AK in Canada may be increasing since 2004. There is a seasonal trend toward disease onset in the warmer months.

Entities:  

Mesh:

Year:  2009        PMID: 19092396     DOI: 10.1097/ICO.0b013e318181a863

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

1.  Seasonal trends of microbial keratitis in South India.

Authors:  Charles C Lin; Prajna Lalitha; Muthiah Srinivasan; N Venkatesh Prajna; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman; Travis C Porco
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  Association Between Season, Temperature and Causative Organism in Microbial Keratitis in the UK.

Authors:  Andrew Walkden; Catherine Fullwood; Shi Zhuan Tan; Leon Au; Malcolm Armstrong; Arun K Brahma; Jaya D Chidambaram; Fiona Carley
Journal:  Cornea       Date:  2018-12       Impact factor: 2.651

Review 3.  Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment.

Authors:  Nóra Szentmáry; Loay Daas; Lei Shi; Kornelia Lenke Laurik; Sabine Lepper; Georgia Milioti; Berthold Seitz
Journal:  J Curr Ophthalmol       Date:  2018-10-19

4.  The relationship between environmental sources and the susceptibility of Acanthamoeba keratitis in the United Kingdom.

Authors:  Nicole A Carnt; Dinesh Subedi; Sophie Connor; Simon Kilvington
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

5.  Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years.

Authors:  Wolfgang List; Wilfried Glatz; Regina Riedl; Georg Mossboeck; Gernot Steinwender; Andreas Wedrich
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 6.  The biology of Acanthamoeba keratitis.

Authors:  Jerry Y Niederkorn
Journal:  Exp Eye Res       Date:  2020-11-19       Impact factor: 3.467

7.  Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes.

Authors:  Michael A Page; William D Mathers
Journal:  J Ophthalmol       Date:  2013-06-12       Impact factor: 1.909

8.  Molecular Characterization of Acanthamoeba Isolates from Surface Resting Waters in Northwest Iran.

Authors:  Esmaeil Fallah; Zahra Jafarpour; Mahmoud Mahami-Oskouei; Ali Haghighi; Maryam Niyyati; Adel Spotin; Aram Khezri
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

Review 9.  Ocular Parasitosis Caused by Protozoan Infection during Travel: Focus on Prevention and Treatment.

Authors:  Morteza Izadi; Mohsen Pourazizi; Mahmoud Babaei; Ali Saffaei; Mohammad-Hasan Alemzadeh-Ansari
Journal:  Int J Prev Med       Date:  2018-09-17

10.  The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes.

Authors:  Anna C Randag; Jeroen van Rooij; Arnoud T van Goor; Samuël Verkerk; Robert P L Wisse; Isabelle E Y Saelens; Remco Stoutenbeek; Bart T H van Dooren; Yanny Y Y Cheng; Cathrien A Eggink
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.